04/25/2024
7:00 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
8:10 AM | Acorda Therapeutics (Subject)
Acorda Therapeutics, Inc. (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
04/17/2024
8:10 AM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:30 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
7:33 AM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:30 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
3:35 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:30 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
6:57 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
BURNS THOMAS M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2023
6:59 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
BURNS THOMAS M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:34 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
Jensen Peder (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:36 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
Kelley John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:37 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
PANEM SANDRA PHD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:38 PM | Acorda Therapeutics (Issuer)
Acorda Therapeutics, Inc. (Issuer)
Varian John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:17 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
7:00 AM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
4:16 PM | Acorda Therapeutics (Filer)
Acorda Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
